Mon, March 15, 2021
Sun, March 14, 2021
Fri, March 12, 2021
Thu, March 11, 2021

Michelle Gilson Maintained (ASND) at Strong Buy with Increased Target to $190 on, Mar 12th, 2021

Michelle Gilson of Canaccord Genuity, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $172 to $190 on, Mar 12th, 2021.

Michelle has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Michelle's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Michelle


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $176 on, Thursday, March 11th, 2021
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $199 on, Friday, November 13th, 2020
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $191 on, Thursday, November 12th, 2020